TALPHERA, INC. Other Selling, General and Administrative Expense
TALPHERA, INC. (TLPH) reported Other Selling, General and Administrative Expense of $1.08 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherSellingGeneralAndAdministrativeExpense · last filed 2026-05-13
- TALPHERA, INC. other selling, general and administrative expense for the quarter ending 2026-03-31 was $1.08M, a 16.07% increase year-over-year.
- TALPHERA, INC. other selling, general and administrative expense for the quarter ending 2025-12-31 was $908.00K, a 13.44% decline year-over-year.
- TALPHERA, INC. other selling, general and administrative expense for the quarter ending 2025-09-30 was $680.00K, a 13.60% decline year-over-year.
- TALPHERA, INC. other selling, general and administrative expense for the quarter ending 2025-06-30 was $1.15M, a 0.09% decline year-over-year.
- TALPHERA, INC. other selling, general and administrative expense for fiscal 2025 was $3.67M, a 16.22% decline from fiscal 2024.
- TALPHERA, INC. other selling, general and administrative expense for fiscal 2024 was $4.38M, a 26.04% decline from fiscal 2023.
- TALPHERA, INC. other selling, general and administrative expense for fiscal 2023 was $5.92M.
| Period end | Other Selling, General and Administrative Expense 3 month | Other Selling, General and Administrative Expense 6 month | Other Selling, General and Administrative Expense 9 month | Other Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $1.08M 10-Q · filed 2026-05-13 | $1.98M derived: sum of 2 quarters · filed 2026-05-13 | $2.66M derived: sum of 3 quarters · filed 2026-05-13 | $3.81M derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | $908.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $1.59M derived: sum of 2 quarters · filed 2026-03-23 | $2.74M derived: sum of 3 quarters · filed 2026-03-23 | $3.67M 10-K · filed 2026-03-23 |
| 2025-09-30 | $680.00K 10-Q · filed 2025-11-12 | $1.83M derived: sum of 2 quarters · filed 2025-11-12 | $2.76M 10-Q · filed 2025-11-12 | $3.81M derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-06-30 | $1.15M 10-Q · filed 2025-08-14 | $2.08M 10-Q · filed 2025-08-14 | $3.13M derived: sum of 3 quarters · filed 2026-05-13 | $3.91M derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-03-31 | $927.00K 10-Q · filed 2026-05-13 | $1.98M derived: sum of 2 quarters · filed 2026-05-13 | $2.76M derived: sum of 3 quarters · filed 2026-05-13 | $3.92M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $1.84M derived: sum of 2 quarters · filed 2026-03-23 | $2.99M derived: sum of 3 quarters · filed 2026-03-23 | $4.38M 10-K · filed 2026-03-23 |
| 2024-09-30 | $787.00K 10-Q · filed 2025-11-12 | $1.94M derived: sum of 2 quarters · filed 2025-11-12 | $3.33M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $1.15M 10-Q · filed 2025-08-14 | $2.54M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $1.39M 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | $5.92M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |